ISSUE NO. 26 | JUNE 2023 THE DIVISION OF MEDICAL ONCOLOGY & HEMATOLOGY
NEWSLETTER
MESSAGE FROM THE CHIEF
Welcome to Our New Staff
Greetings members of the
Division of Medical Oncology and
Hematology. Kevin Dawe joined DMOH as a Physician Assistant.
Prior to this he worked at CancerCare Manitoba since
I would like to welcome you to 2012 in the Leukemia and BMT clinic. He also has a
our June 2023 issue! I am pleased faculty appointment with the University of Manitoba
to highlight our many milestones Master’s of Physician Assistant Education Program and
and achievements in the past is the course coordinator for the programs patient
month. In the next few pages, you assessment course. Kevin graduated from the University
will read about: of Waterloo in 2010 with a Bachelor of Science Degree
with a Specialization in Kinesiology then completed his
• New staff Master’s of Physician Assistant Studies at the University
of Manitoba in 2012. Kevin is also an international figure
• Outstanding awards & skating coach who recently coached two national medalists and in March 2023
accomplishments coached a pairs team who represented Canada at the 2023 Junior World Figure
• Celebrating Nancy Vukovic’s Skating Championships.
Retirement
• Research Achievements
Olivia Ly joined DMOH as an Administrative Assistant
• Staff spotlights supporting Drs. Dave Cescon and Vikaash Kumar and
• Upcoming events thanks Diana Burgos for telling her about this position.
Prior to this she worked as the JDMI PET/CT Appoint-
Please feel free to share this ment Scheduler in the Central Booking Office. She has
newsletter with colleagues. We completed an undergraduate degree in Psychology and
also welcome your feedback, a Medical Office Assistant program prior to joining UHN.
content, and suggestions for In her spare time, she likes to find new restaurants and
future issues. events happening in the city to go to. Please let her know
if you have any recommendations!
Happy reading,
Amit Oza
Always Moving Forward
In June we launched our new Always Moving Forward strategic priorities at Prin-
cess Margaret. For more information please visit the website where you can
also access the full plan and please take a minute to watch the short summary
overview video.
DMOH Newsletter PAGE 1
STAFF ACHIEVEMENTS
Congratulations to Our Staff
Dr. Jacob Pendergrast contrib-
uted to the following Knowledge
Congratulations to Dr. Hassan mobilization resources and activi-
Sibai for receiving the Jerry Scott ties:
Faculty Teaching Award from the
Division of Hematology, Depart- Knowledge Mobilization
ment of Medicine at the University Resources
of Toronto. This award recognizes RBC Transfusions: Historical vs
the outstanding educational Best Practices. Transfusion Medi-
contribution to the Division of cine Boot Camp for Nurses [online]
Hematology and to the Faculty
of Medicine in the area of under- • Management of Sickle Cell Disease. Humber College
graduate, postgraduate and/or Sickle Cell Disease Symposium in Toronto.
continuing professional education. • Pain Management in Sickle Cell Disease. North York
General Hospital Black History Month in Toronto.
• Hyperhemolysis in Sickle Cell Disease. 2nd Annual
Ontario Sickle Cell Summit [online]
Knowledge Mobilization Activities
Congratulations to Dr. Helena • Contributed to the to the development of a Terms of
Dhamko for being awarded the Reference and mandate of the Canadian Transfusion
University Health Network and Trials Group (CTTG), Mentorship Working Group and
Sinai Health Teacher of the Year was tasked with professional development of the CTTG
Award. This annual award is issued membership.
to the UHN/SH Department of • Served as a committee member on the Ontario
Medicine faculty with the highest Health Sickle Cell Disease Quality Standard Advisory
Teaching Effectiveness (TES) score. Committee, with the key objective of providing advice
on the development of the quality standard that will
be used to improve the care for people with sickle cell
disease in Ontario.
In June, 3,500 survivors, patients, donors and
UHN staff joined the Ride to Conquer Cancer. The
ride raise $17.3 million to help accelerate Cancer
research. Big shout out to the teams at the PM
foundation for once again organizing an amazing On June 15, Walaa Keir and Dr. Hassan Sibai picked up the
event. With special acknowledgment to the Ride following awards from the Wightman-Berris Academy:
leaders Steve Merker and Ryan Baillie and the
huge team of volunteers who inspired the confi- • Walaa Keir received the Anne Marie Holmes Award for
dent and healthy teams who participated. 2022-2023 for the impact she has had on learners.
• Dr. Hassan Sibai received the Individual Teaching
Excellent Award in the Postgraduate category for 2022-
2023 for the impact he has had on learners.
DMOH Newsletter | June 2023 PAGE 2
STAFF ACHIEVEMENTS
Celebrating Nancy Vukovic’s Retirement
DMOH Newsletter | June 2023 PAGE 3
STAFF ACHIEVEMENTS
The 2023 ASCO Annual Meeting held in June was an all-access pass to join global cancer experts and to discover the latest innova-
tions in cancer research and education. This year's program featured over 200 sessions complementing Dr. Eric Winer's Presiden-
tial theme Partnering With Patients: The Cornerstone of Cancer Care and Research. DMOH has had an outstanding year, with many
of our staff and learners receiving significant awards and showcasing poster sessions, presentations and co-authoring content.
Please click here for a summary of some of the DMOH staff and learners who received awards, presented and co-authored
content at ASCO this year.
The ASCO Young Investigator Award provides research funding to promising young physicians during the final years of training
to support the transition to a faculty appointment and to encourage quality research in clinical oncology.
The Novartis Oncology Young Canadian Investigator Award (NOYCIA) provides funding, support and recognition to ten
researchers that demonstrate excellence in their specialist field of study.
The ASCO Merit Award recognizes high-quality abstracts submitted to an ASCO Meeting by trainees and students and encour-
ages their attendance at the Meeting.
Congratulations to Dr. Enrique Sanz Garcia for receiving Congratulations to Dr. Pavlina Spiliopoulou for receiving
the following awards: the following awards:
• Young Investigator Award in honor of Suzy Williams • Debra Lesavoy Women Who Conquer Cancer Conquer
Phillips for the project “Detection of ctDNA and/or HPV Cancer Young Investigator Award for the project
DNA in high risk locally advanced head and neck squa- “Prospective Analysis of INteStinal Microbiome and
mous cell carcinoma (LA-HNSCC): The PRE-MERIDIAN Autoimmune PanEls asPrediCtors of Toxicity in Immu-
(Molecular residual disease interception in high risk nOncology Patients (INSPECT-IO)”. Her mentor was Dr.
LA-HNSCC) study”. His mentors were Drs. Lillian Siu Anna Spreafico.
and Scott Bratman.
• Novartis Oncology Young Canadian Investigator Award
• Novartis Oncology Young Canadian Investigator Award for the project titled “Intestinal microbiome character-
for the poster “Multimodal detection in plasma of ization in immune checkpoint inhibition (ICI) resistant
molecular residual disease (MRD) in locally advanced disease”. Her mentor was Dr. Anna Spreafico.
head and neck squamous cell carcinoma (LA-HNSCC)”.
His mentor was Dr. Lillian Siu. • ASCO Merit Award for the project “Intestinal micro-
biome characterization in immune checkpoint inhibi-
tion (ICI) resistant disease”. Her mentor was Dr. Anna
Spreafico.
DMOH Newsletter | June 2023 PAGE 4
STAFF ACHIEVEMENTS
Congratulations to Dr. Gordon Taylor Moffat for receiving Congratulations to Dr. Elizabeth Faour for receiving the
the following awards: following awards:
• Novartis Oncology Young Canadian Investigator • Novartis Oncology Young Canadian Investigator Award
Award for the project "Characterizing KRAS allele vari- for the poster presentation “The influence of sex on the
ants within biliary tract cancers”. His mentor was Dr. impact of age and frailty on acute care use among older
Jennifer Knox. adults receiving immune checkpoint inhibitor (ICI) treat-
• ASCO Merit Award for the abstract “Characterizing KRAS ment: A population-based study”. Her mentors were
allele variants within biliary tract cancers”. His mentor Drs. Shabbir Alibhai and Lawson Eng.
was Dr. Jennifer Knox. • ASCO Merit Award for her poster presentation “The
influence of sex on the impact of age and frailty on
acute care use among older adults receiving immune
checkpoint inhibitor (ICI) treatment: A population-based
study”. Her supervisors were Drs. Lawson Eng and
Shabbir Alibhai.
Congratulations to Dr. Jesús Fuentes Antras for receiving
the Young Investigator Award for the research project
“Tumor-informed ctDNA dynamics in HR+/HER2- metastatic
breast cancer patients receiving first-line CDK4/6 inhibitors”.
His mentor was Dr. Dave Cescon.
Congratulations to Dr. Sofia Genta for receiving the
Novartis Oncology Young Canadian Investigator Award for
the abstract “Deciphering primary and acquired immuno-
therapy resistance with whole genome and transcriptome
analysis (WGTA)”. Her mentor was Dr. Anna Spreafico.
Congratulations to Dr. Alberto Hernando Calvo for
receiving the Conquer Cancer – Flatiron Health Elevate
the Science Endowed Merit Award supported by Flatiron
Health Inc. for the poster “Impact on costs and outcomes
of multi-gene panel testing for advanced solid malignan- Congratulations to Dr. Thais Megid for receiving the ASCO
cies: A cost consequence analysis using linked administra- Merit Award for the abstract “Leptomeningeal carcinoma-
tive data?” This Merit Award recognizes a trainee or student tosis and brain metastases in gastroesophageal carcinoma:
who submitted a high scoring abstract focused on obser- A real-world analysis of outcomes, clinical and pathologic
vational research, as determined by the Scientific Program characteristics”. Her mentors were Drs. Elena Elimova,
Committee. His supervisors were Drs. Philippe Bedard Lucy Ma, and Raymond Jang.
and Timothy Hanna.
DMOH Newsletter | June 2023 PAGE 5
STAFF ACHIEVEMENTS
DMOH Newsletter
ISSUE NO. 26 | JUNE 2023
produced by the Division of Medical
Oncology and Hematology at the
Congratulations to Dr. Farooq Abdulrehman for receiving Princess Margaret Cancer Centre
the ASCO Merit Award for the poster “Tandem dupli-
cator phenotype: a novel targetable subgroup in pancre- Please forward submissions and comments to
atic cancer?” His supervisors were Drs. Erica Tsang and [email protected]
Jennifer Knox.
DMOH Communications
Team & Content Advisors
Congrats to Christina Gulesse-
rian for completing a certificate in James Austin
Improving Your Business Through Christina Gulesserian
a Culture of Health from Harvard Michelle Williams
University.
Contributors
Alberto Hernando Calvo
Amit Oza
Aniket Bankar
Elizabeth Faour
Enrique Sanz Garcia
Farooq Abdulrehman
Geoffrey Liu
Gordon Taylor Moffat
Hannah Cherniawsky
Hassan Sibai
Helena Dhamko
Jacob Pendergrast
Jennifer Ryan
Jesús Fuentes Antras
Katty MacLean
Compliment A Keith Stewart
Kevin Dawe
Physician Lawson Eng
Long Nguyen
Nadine Shehata
Have you had a great Natasha Leighl
experience with an Ontario Olivia Ly
doctor? Oncology Education
Pavlina Spiliopoulou
Let the CPSO know about the excellent care Princess Margaret Cancer Foundation
you received by submitting a compliment. Shereen Ezzat
In most cases, the CPSO will pass along Sofia Genta
your message to the physician or surgeon. Stephanie Lheureux
Steven Chan
Information can be found here. Thais Megid
Valentina Bruno
Valerie Bowering
DMOH Newsletter | June 2023 PAGE 6
STAFF ACHIEVEMENTS
Notable Research Achievements
Congratulations to Dr. Natasha
Leighl for being elected to the
Board of Directors of the Interna-
tional Association for the Study of
Lung Cancer (IASLC), the world's
leading society for advancing
research and treatment of thoracic
cancers. Dr. Leighl will serve a
four-year term (2023-2027) and
will help shape the direction and
strategy of the IASLC, following in
the footsteps of Dr. Frances Shepherd, Dr. Andrea Bezjak
and Dr. Ming Tsao. This achievement is a tribute to the excel-
lence of the Princess Margaret Thoracic Oncology Program
Medicine by Research.com recognizes the top 500 and Dr. Leighl's international reputation and tremendous
Ranking of Best Scientists from UHN's Depart- respect from the global thoracic oncology community.
ment of Medicine and University of Toronto's
Temerty Faculty of Medicine. Congratulations to
these members of UHN's Department of Medicine
and the University of Toronto's Temerty Faculty Congratulations to Dr. Nadine
of Medicine for being featured in the top 500 in Shehata for receiving a grant
Canada of the 2023 Edition of our Ranking of Best award from the International
Scientists in the field of Medicine by Research.com: Society on Thrombosis and
Drs. Frances Shepherd, Geoffrey Liu,and Lillian Haemostasis Scientific and Stan-
Siu. dardization Committee for “Under-
The ranking is based on D-index (Discipline H-index) standing shared decision-making
metric, which only includes papers and citation process regarding the choice
values for an examined discipline. The ranking of anticoagulant for pregnant
includes only leading scientists with D-index of at patients with mechanical heart
least 70 for academic publications made in the valves: an international qualitative
area of medicine. Research.com's best scientists research study”. Principal Investigator: Dr. Nadine Shehata,
ranking is a trustworthy list of leading scholars from SSC Subcommittee on Women’s Health Issues in Throm-
the area of medicine, based on a thorough study of bosis and Hemostasis.
166,880 researchers identified from various biblio-
metric data sources. For the field of medicine, as
many as 68,936 scholars were analyzed. Their goal
is to inspire scientists, entrepreneurs and politi- Congratulations to Dr. Long
cians worldwide to examine where prominent Nguyen for receiving the
experts are heading and to offer a way for the Research Stimulus Grant award
whole research community to discover who the for the project “Indexing pheno-
leading experts in specific areas of study, in various type, function, and genetic
countries, or even within research institutions are. susceptibilities with single cell
multiomics”. Supported by the
The full world ranking is available here. The full Princess Margaret Cancer Foun-
ranking for Canada is available here.
dation, Research Stimulus Grants
are designed to enable Princess
Margaret researchers to accel-
erate their programs and to continue investing in bold
and high-gain projects. Dr. Nguyen’s project will investi-
gate chemotherapy resistance in patient-derived xeno-
graft models of human breast cancer by integrating single
cell multiomics with cell phenotype, function and genetic
susceptibilities using an in vivo targeted CRISPR screening
approach.
DMOH Newsletter | June 2023 PAGE 7
STAFF ACHIEVEMENTS
Launch of the Cancer Clinical Research Unit (CCRU)
Convergence Centre
The Cancer Clinical Research Unit (CCRU) Convergence Centre opened in June for its first patients. This dedicated clinical
research facility is the first of its kind at UHN, and will support Princess Margaret’s translational medicine initiatives, and its
clinical research enterprise.
The CCRU Convergence Centre hosts a patient lounge, 8 blood collection bays, and 8 exam rooms. The unit has direct
access to the CCRU Correlative Studies Laboratory, allowing rapid collection and processing of correlative research samples,
maximizing efficiency and sample quality. In addition to blood collection, the unit is outfitted to support the collection of
non-image guided biopsies, such as punch biopsies and aspirates, patient rooms for post-treatment monitoring and pK
collections, and priority access to private rooms to consent patients to studies exploring translational research.
To elevate the patient experience, patients will be welcomed into a dedicated space where they are at the centre of their
research care. Research staff will meet their patients in the Convergence Centre to complete research activities, and
patients will have the opportunity to rest and recharge in the lounge between appointments.
A large thank-you to the Princess Margaret Foundation for supporting this initiative, Brad Wouters and the CFI Awards
team, Aaron Schimmer for providing space, Peter Ashton, and Steven Corfe and the Facilities team for the project manage-
ment and our patient partners who helped co-design and inspired this one-of-a-kind space.
In addition, a very special thank-you to Marcia Flynn-Post, Cassandra Mayor, Vanessa Speers, Susanna Sellmann, Heather
Cole, Katherine Karakasis, Kamal Garcha, and Pamela Degendorfer for all the phenomenal work that has gone into bringing
the Convergence Centre from idea to reality.
Our patients and Princess Margaret Research benefit from our collaborative efforts, and ongoing commitment to
Conquering Cancer Together.
In preparation for regular operations, the CCRU Convergence Centre soft opening will initially support studies with support
from CCRU PK and CSP Teams. Congratulations.
DMOH Newsletter | June 2023 PAGE 8
STAFF ACHIEVEMENTS
Congratulations to Dr. Steven
Chan for receiving the Research
Stimulus Grant for the project
“Investigating the functional role
of mitochondrial DNA mutations
in AML development”. Somatic
mutations in mitochondrial DNA
(mtDNA) are found in a variety of
human cancers including acute
myeloid leukemia (AML). However,
their role in cancer development is
controversial and unclear. In this project, we will use newly
developed tools to introduce specific mtDNA mutations in
hematopoietic cells and determine the impact of the muta-
tions on the growth and differentiation of the genetically-
engineered cells. Our project will unveil key insights into the Congratulations to Dr. Gopila Gupta for winning the best
role of mtDNA mutations in oncogenesis and potentially abstract award in the clinical-malignant hematology cate-
new therapeutic targets.
gory at University of Toronto Annual Hematology Academic
Day for “Clinical and molecular factors associated with
thrombosis in myelofibrosis”. Co-authors include Drs. Vikas
Gupta, Dawn Maze, Hassan Sibai, Marta Davidson,
Jose-Mario Capo-chichi, Hubert Tsui, Aniket Bankar, Elliot
Smith, and Verna Cheung.
Congratulations to Dr. Stephanie
Lheureux for her paper "Camon-
sertib in DNA damage response-
deficient advanced solid tumors:
phase 1 trial results" published in
Congratulations to Drs. Aniket Bankar, Vikas Gupta, and Nature Medicine. Thank you to all
Shabbir Alibhai for their paper “Prevalence and Associa- the co-investigators, Ashley Adile,
tion of Frailty with Clinical Outcomes in Myeloproliferative the Drug Development Program
Neoplasms: A Population-Based Study” published in Blood -Phase II team and the Gyne & GI
Advances. clinical trial nursing teams.
Congrats to Drs. Mark Minden
for his paper “Transcriptomic
classes of BCR-ABL1 lympho-
Congratulations to Dr. Shereen blastic leukemia” published in
Nature Genetics.
Ezzat for his paper “The Driver
Role of Pathologists in Endocrine
Oncology: What Clinicians Seek
in Pathology Reports” published
in Endocrine Pathology. Four senior
Endocrine Oncologists from
Oxford, Erasmus, Turin, and PMH
discuss the spectrum of endocrine Congratulations to Drs. Christo-
cancers. Uniquely, they highlight pher Patriquin and David Barth
critical information they seek in for their paper “Impact of Intra-
pathology reporting to help them shape cancer manage- operative Therapeutic Plasma
ment plans. The exercise also uses specific examples to Exchange on Bleeding in Lung
facilitate communication between clinicians and patholo- Transplantation” published in the
gists. Journal of Heart and Lung Trans-
plantation.
DMOH Newsletter | June 2023 PAGE 9
STAFF ACHIEVEMENTS
Congratulations to Drs. Stephanie Lheureux, Neesha
Congratulations to Drs. Abhenil Mittal, Srikala Sridhar, Dhani and Amit Oza for their paper “Identifying mecha-
and Maria (Di) Jiang for their paper "Triplet Therapy in nisms of resistance by circulating tumour DNA in EVOLVE,
a Phase II Trial of Cediranib Plus Olaparib for Ovarian
Metastatic Castrate Sensitive Prostate Cancer (mCSPC)
- A Potential New Standard of Care" published in Current Cancer at time of PARP Inhibitor Progression” published in
Oncology. Clinical Cancer Research.
Congratulations to Drs. Anca Prica, Dawn Maze, Chris-
tine Brezden-Masley, and Eitan Amir for their paper
“Statins to prevent early cardiac dysfunction in cancer
patients at increased cardiotoxicity risk receiving anthra-
cyclines” published in European Heart Journal Cardiovascular
Pharmacotherapy.
Congratulations to Andrea Arruda, Dr. Vikas Gupta, Dr.
Dawn Maze, Dr. Mark Minden, Dr. Aaron Schimmer,
Dr. Hassan Sibai, Dr. Karen Yee, Jose-Mario Capo-
Chichi, Tracy Stockley, Dr. Andre Schuh, Dr. Scott
Bratman and Dr. Steven Chan for their paper “Exclusion
of persistent mutations in splicing factor genes and isoci-
trate dehydrogenase 2 improves the prognostic power
of molecular measurable residual disease assessment in
acute myeloid leukemia” published in Haematologica.
Congratulations to Drs. Enrique Sanz Garcia, Sofia
Genta, Albiruni Abdul Razak, Anna Spreafico, Lillian
Siu, and Philippe Bedard for their paper “Tumor-Naïve
Circulating Tumor DNA as an Early Response Biomarker
for Patients Treated With Immunotherapy in Early Phase Congratulations to Drs. Mark Minden and Jean Wang
Clinical Trials” published in the American Society of Clinical for their paper “A cellular hierarchy framework for under-
standing heterogeneity and predicting drug response in
Oncology Journal.
acute myeloid leukemia” published in Nature Medicine.
DMOH Newsletter | June 2023 PAGE 10
STAFF SPOTLIGHTS
Get to Know
Valentina Bruno
Dr. Valentina Bruno is a paediatric nephrologist with interest in renal
replacement therapies, glomerular diseases and complement-mediated
disorders. She completed her medical degree and general paediatric
training at the University Federico II in Naples, Italy, and her paediatric
nephrology fellowship at The Hospital for Sick Children (SickKids), Univer-
sity of Toronto, ON, Canada.
Dr. Bruno was the inaugural “Complement-Mediated Diseases and
Apheresis” fellow at the University of Toronto (2021-2023) under the
supervision of Drs. Christoph Licht and Christopher Patriquin. This
fellowship provided her with the opportunity of gaining unique insights
into the pathogenesis of complement-mediated diseases and their
treatments, expertise which will ultimately contribute to improving the
clinical outcomes and the quality of life of patients with complement-mediated disorders. During her fellowship,
Dr. Bruno engaged in a basic-science project focusing on the role of the complement system in the pathogen-
esis of primary membranous nephropathy, by using an in-vitro model of immortalized human podocytes. Her
research in the laboratory of Dr. Christoph Licht led to the successful completion of a Master of Science (MSc)
degree at the University of Toronto in August 2022, and was awarded the prestigious Clinician-Scientist Training
Program Fellowship at the SickKids Research Institute. Dr. Bruno also received the best basic science award
at the Young Investigators Forum of the 3rd Toronto Complement Conference (TCC 2022), and at the Annual
Meeting of the Canadian Association of Paediatric Nephrology (2023).
What do you like most about your job?
It allows me to translate my research findings into clinical practice, with the ultimate goal of ensuring the best
care to children with kidney disease. I firmly believe that children are the most inspirational patients, able to
respond to illness in an unexpected way. Having the opportunity to help and support them during their most
vulnerable time is a true privilege.
What’s a fun fact about you that others may not know?
When I was a child I wanted to become an elementary school teacher. Growing up my dreams have changed
somewhat, but I knew from the very beginning I wanted to take care of children.
What do you enjoy doing when you’re
not working?
I love travelling, experiencing new cultures
and capturing the unexpected moments!
What is the best advice you have ever
received?
Don’t follow the crowd. Always be yourself
and advocate your ideas.
STAFF SPOTLIGHTS
Get to Know
Hannah Cherniawsky
Hannah Cherniawsky is originally from Edmonton but had been living
in Vancouver for the past 3 years before moving to Toronto. She has
become very weak in the cold! Hannah trained in Hematology, and
then Transplant and Leukemia. She is fulfilling her goal of getting more
experience with CAR T-cell therapy as we work to set up a provincial
program in BC. She is married to an amazing high school teacher who
is the millennial version of Bill Nye.
What do you like most about your job?
I enjoy the detective work of hematology as both a diagnostic and
therapeutic specialty.
What’s a fun fact about you that others may not know?
I’m a huge fan of documentaries, podcasts and naps.
What do you enjoy doing when you’re not working?
Anyone who walks past my desk knows my dog (Ellie – the queen
of Toronto) is my life. Together we love rock climbing and running!
What is the best advice you have ever received?
I’m sure people can relate to the amount of solicited and unsolicited advice we receive. I think
it is important to question advice that may be based on someone else’s idea of you rather
than what you really want. I was told by a mentor that I would be bored in hematology and
needed to do ICU. I am forever grateful I did not listen to that advice.
Physician Health Program
The PHP welcomes self-referrals from medical students, residents, physicians and
veterinarians in Ontario who may have concerns about their health and well-being.
Their confidential services are here to assist those experiencing distress, substance
use or mental health issues that can have personal or professional impact.
Call the confidential PHP number toll free at 1-800-851-6606 from 8:45 am to
5:00 PM. Email: [email protected]
EVENTS & DEADLINES
Best of ASCO Seattle curates the most clinically rele-
vant content from the ASCO Annual Meeting so you
can take home valuable, actionable insights that can
be immediately applied in your practice.
Date: July 21-23, 2023
Registration Link
Join Muskoka’s premier cycling and fundraising event
and support the next big cancer breakthrough. Don’t
miss your chance to ride while taking in the breath-
taking views along Lake Muskoka. There are three
unique routes to choose from and plenty of reasons
to take part.
Date: August 12, 2023
Registration Link
OncologyEducation’s Best of ASCO® Montreal 2023
Conference is a program licensed by the American
As innovations in cancer care technology accelerate Society of Clinical Oncology® and will be an all-day
progress and improve patient outcomes, ASCO Break- hybrid event on July 12th, 2023. Chaired by Dr. Jamil
through brings together oncology thought leaders, Asselah and Dr. Kim Ma, the focus of this event will be
practicing clinicians, med-tech pioneers, novel drug to provide medical oncologists and other healthcare
developers, and research trailblazers at this can’t-miss practitioners with a summary of the most significant
oncology meeting in Asia for inspiration, collaboration, treatment advances presented at The 2023 ASCO®
and solutions. Annual Meeting, with presentations focused on several
key disease sites. The Best of ASCO® Montreal 2023
Date:: August 3-5, 2023 faculty will draw from some of Canada’s most influen-
tial oncologists.
Registration Link
Date:: July 12, 2023
Registration Link
DMOH Newsletter | June 2023 PAGE 13